These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 39030504)

  • 21. Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study.
    Irfan E; Dilshad E; Ahmad F; Almajhdi FN; Hussain T; Abdi G; Waheed Y
    BMC Infect Dis; 2024 May; 24(1):495. PubMed ID: 38750422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
    Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
    Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M; Mustafa G; Mahrosh HS
    Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents.
    Kanjanasirirat P; Suksatu A; Manopwisedjaroen S; Munyoo B; Tuchinda P; Jearawuttanakul K; Seemakhan S; Charoensutthivarakul S; Wongtrakoongate P; Rangkasenee N; Pitiporn S; Waranuch N; Chabang N; Khemawoot P; Sa-Ngiamsuntorn K; Pewkliang Y; Thongsri P; Chutipongtanate S; Hongeng S; Borwornpinyo S; Thitithanyanont A
    Sci Rep; 2020 Nov; 10(1):19963. PubMed ID: 33203926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoronavirus activity of rhizome of Dryopteris crassirhizoma via multistage targeting of virus entry and viral proteases, Mpro and PLpro.
    Habib M; Jin YH; Kim Y; Min JS; Ha IJ; Lee SM; Kwon S
    J Ethnopharmacol; 2024 Oct; 333():118490. PubMed ID: 38925321
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    El Gizawy HA; Boshra SA; Mostafa A; Mahmoud SH; Ismail MI; Alsfouk AA; Taher AT; Al-Karmalawy AA
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.
    Gyebi GA; Elfiky AA; Ogunyemi OM; Ibrahim IM; Adegunloye AP; Adebayo JO; Olaiya CO; Ocheje JO; Fabusiwa MM
    Comput Biol Med; 2021 Sep; 136():104671. PubMed ID: 34332348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
    Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using
    Rasul HO; Thomas NV; Ghafour DD; Aziz BK; Salgado M G; Mendoza-Huizar LH; Candia LG
    J Biomol Struct Dyn; 2024 May; 42(8):4234-4248. PubMed ID: 37349945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phytochemical rich Himalayan
    Lingwan M; Shagun S; Pahwa F; Kumar A; Verma DK; Pant Y; Kamatam LVK; Kumari B; Nanda RK; Sunil S; Masakapalli SK
    J Biomol Struct Dyn; 2023 Mar; 41(4):1403-1413. PubMed ID: 34961411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolites profiling and cheminformatics bioprospection of selected medicinal plants against the main protease and RNA-dependent RNA polymerase of SARS-CoV-2.
    Lanrewaju AA; Enitan-Folami AM; Nyaga MM; Sabiu S; Swalaha FM
    J Biomol Struct Dyn; 2024 Aug; 42(13):6740-6760. PubMed ID: 37464870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach.
    Bhowmick S; Saha A; Osman SM; Alasmary FA; Almutairi TM; Islam MA
    Mol Divers; 2021 Aug; 25(3):1979-1997. PubMed ID: 33844135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
    Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
    Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease.
    Yuda GPWC; Hanif N; Hermawan A
    Daru; 2024 Jun; 32(1):47-65. PubMed ID: 37907683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2.
    Al-Karmalawy AA; Farid MM; Mostafa A; Ragheb AY; H Mahmoud S; Shehata M; Shama NMA; GabAllah M; Mostafa-Hedeab G; Marzouk MM
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diterpenoid and C20 diterpenoid alkaloid as a potent inhibitor of SARS-CoV-2 main protease (M
    Surendran VA; Ibrahim JM; Thodi RC; Nair AS; Sukumaran ST
    J Biomol Struct Dyn; 2024 Aug; 42(13):6997-7013. PubMed ID: 37482792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection.
    Samy A; Hassan A; Hegazi NM; Farid M; Elshafei M
    Sci Rep; 2024 May; 14(1):12059. PubMed ID: 38802394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
    Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM
    J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease.
    Alaaeldin R; Mustafa M; Abuo-Rahma GEA; Fathy M
    Fundam Clin Pharmacol; 2022 Feb; 36(1):160-170. PubMed ID: 34268806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.